Novavax, Inc.

US$10.78As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:NVAXHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (9.83%)
Div yield —
ROE —
Biotechnology
Beta (5Y) 2.72
PE TTM —
TSR TTM 28.33%
Mkt cap US$1.779B
ROIC (11.81%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$12
12.26%
(96.70%)
Hold 1|6|7|11|2
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.10
0.11
0.12
0.12
0.22%
7.52%
13.78%
18.55%
Revenue$M
76.97
79.75
79.79
84.54
1.14%
7.69%
4.87%
8.00%
Peers (US$1.779B)
Cap (US$)
PE
1.745B
—
1.810B
—
Capital
TTM
5Y
10Y
Leveragex
3.151
0.111
0.108
EBIT/Intx
10.16
0.118
0.110
Own earn%
(107.40)
(46.26)
(55.14)
Sh yield%
44.49
43.90
45.35
Owners
Insiders/Inst%
12.55
38.76
Short interest%
1.52
SBC / revenue%
3.80
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
4
Op margin range%
0–4
$1 testx
0.1
Incr. ROIC%
7